Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Hyperfine, a health technology company known for its FDA-cleared portable MR brain imaging system, the Swoop®, will present at the Jefferies Global Healthcare Conference in New York on June 6, 2024, at 3:00 pm ET. The event will be live-streamed and archived on the company's investor relations website for 90 days. For more details about the Swoop® system, visit their official website.

Positive

• Hyperfine's Swoop® system is the first FDA-cleared portable MR brain imaging system.
• The company will gain exposure by presenting at the Jefferies Global Healthcare Conference.
• A live webcast and archived recording of the presentation will be available, enhancing transparency and accessibility for investors.
• The webcast will be available for 90 days, allowing investors ample time to review the presentation.

Negative

• The press release did not mention any new financial or clinical data, potentially leaving investors wanting more substantial updates.
• There is no indication of new product releases or significant business developments in the announcement.

GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference, in New York, NY. Members of management are scheduled to present on Thursday, June 6, 2024, at 3:00 pm ET.

A live webcast of the event, as well as an archived recording will be available on the “Investors” section of the company’s website at: investors.hyperfine.io. The webcasts will be archived and available for replay for at least 90 days after the event.

For more information about the Swoop® Portable MR Imaging® system, please visit hyperfine.io.

About Hyperfine, Inc. and the Swoop® Portable MR Imaging® System

Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a portable magnetic resonance brain imaging device for producing images that display the internal structure of the head where a full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The Swoop® system has been approved for brain imaging in several countries, including Canada and Australia, has UKCA certification in the United Kingdom, CE certification in the European Union, and is also available in New Zealand.

The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. Traditionally, access to costly, stationary, conventional MRI technology can be inconvenient or not available when needed most. With the portable, ultra-low-field Swoop® system, Hyperfine, Inc. is redefining the neuroimaging workflow by bringing brain imaging to the patient’s bedside. For more information, visit hyperfine.io.

Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522798260/en/

Investor Contact

Webb Campbell

Gilmartin Group LLC

webb@gilmartinir.com

Source: Hyperfine, Inc.

FAQ

What will Hyperfine (HYPR) present at the Jefferies Global Healthcare Conference?

Hyperfine will present their portable MR brain imaging system, the Swoop®, at the Jefferies Global Healthcare Conference on June 6, 2024.

When is Hyperfine (HYPR) presenting at the Jefferies Global Healthcare Conference?

Hyperfine is scheduled to present on June 6, 2024, at 3:00 pm ET.

How can I watch Hyperfine's (HYPR) presentation at the Jefferies Global Healthcare Conference?

A live webcast of Hyperfine's presentation will be available on the company’s investor relations website, with an archived recording accessible for 90 days.

What is Hyperfine's (HYPR) Swoop® system?

The Swoop® system is Hyperfine's FDA-cleared portable MR brain imaging system.

Where can I find more information about Hyperfine's (HYPR) Swoop® system?

More information about the Swoop® system can be found on Hyperfine's official website at hyperfine.io.